24/7 Market News- Hoth Therapeutics Prepares for Clinical Trials of HT-ALZ following US Patent Award for Alzheimer’s Treatment

October 15, 2024

DENVER, Colo., Oct 15, 2024 (247marketnews.com)- Hoth Therapeutics (NASDAQ: HOTH) reported receiving a U.S. patent for its HT-ALZ, an Alzheimer’s treatment breakthrough that specifically targets the Substance P/Neurokinin-1 Receptor pathway, which is known to play a critical role in neuroinflammation.

“This patent marks a significant achievement for Hoth as we progress HT-ALZ from the lab to clinical development. The preclinical data on neuroinflammation reduction and cognitive improvement offer great hope, and we are excited to take the next critical steps toward delivering a potentially life-changing therapy to Alzheimer’s patients,” stated Robb Knie, CEO of Hoth Therapeutics.

Hoth Therapeutics is preparing clinical trials to further validate HT-ALZ’s efficacy in humans, following completion of the formulation phase.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (HOTH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.